This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2020 Oct;38(10):1132-1145.

doi: 10.1038/s41587-020-0697-7.

Whither COVID-19 vaccines?

Laura DeFrancesco¹

Affiliations

PMID: 32989315
PMCID: PMC7520880
DOI: 10.1038/s41587-020-0697-7

Whither COVID-19 vaccines?

Laura DeFrancesco. Nat Biotechnol. 2020 Oct.

. 2020 Oct;38(10):1132-1145.

doi: 10.1038/s41587-020-0697-7.

Author

Laura DeFrancesco¹

Affiliation

¹ Nature Biotechnology, . l.defrancesco@us.nature.com.

PMID: 32989315
PMCID: PMC7520880
DOI: 10.1038/s41587-020-0697-7

Abstract

Nature Biotechnology convenes a group of experts to provide their insights into SARS-CoV-2 vaccines in development.

PubMed Disclaimer

Figures

None — Galit Alter, Harvard Medical School and Ragon Institute.

None — Larry Corey, Fred Hutchinson Cancer Research Center.

None — Rino Rappuoli, GlaxoSmithKline.

None — Kate Bingham., SV Health Managers and UK Vaccines Taskforce. Tom Kates

None — James Dahlman, Georgia Institute of Technology.

None — Nick Jackson, CEPI.

None — COVID-19 vaccine candidates under development. Adapted with permission from ref. , Springer Nature.

None — Stages of development of COVID-19 vaccine candidates. Adapted with permission from https://vac-lshtm.shinyapps.io/ncov_vaccine_landscape/, Vaccine Center at the London School of Hygiene and Tropical Medicine.

None — COVID-19 clinical trials by stage of development. Source: London School of Hygiene and Tropical Medicine.

None — Vaccine developers. Adapted with permission from ref. , Springer Nature.

See this image and copyright information in PMC

Similar articles

Approaches and Challenges in SARS-CoV-2 Vaccine Development.
Dagotto G, Yu J, Barouch DH. Dagotto G, et al. Cell Host Microbe. 2020 Sep 9;28(3):364-370. doi: 10.1016/j.chom.2020.08.002. Epub 2020 Aug 10. Cell Host Microbe. 2020. PMID: 32798444 Free PMC article. Review.
COVID-19 herd immunity: where are we?
Fontanet A, Cauchemez S. Fontanet A, et al. Nat Rev Immunol. 2020 Oct;20(10):583-584. doi: 10.1038/s41577-020-00451-5. Nat Rev Immunol. 2020. PMID: 32908300 Free PMC article.
DNA vaccine protection against SARS-CoV-2 in rhesus macaques.
Yu J, Tostanoski LH, Peter L, Mercado NB, McMahan K, Mahrokhian SH, Nkolola JP, Liu J, Li Z, Chandrashekar A, Martinez DR, Loos C, Atyeo C, Fischinger S, Burke JS, Slein MD, Chen Y, Zuiani A, Lelis FJN, Travers M, Habibi S, Pessaint L, Van Ry A, Blade K, Brown R, Cook A, Finneyfrock B, Dodson A, Teow E, Velasco J, Zahn R, Wegmann F, Bondzie EA, Dagotto G, Gebre MS, He X, Jacob-Dolan C, Kirilova M, Kordana N, Lin Z, Maxfield LF, Nampanya F, Nityanandam R, Ventura JD, Wan H, Cai Y, Chen B, Schmidt AG, Wesemann DR, Baric RS, Alter G, Andersen H, Lewis MG, Barouch DH. Yu J, et al. Science. 2020 Aug 14;369(6505):806-811. doi: 10.1126/science.abc6284. Epub 2020 May 20. Science. 2020. PMID: 32434945 Free PMC article.
Impact of glycoscience in fighting Covid-19.
Adamo R, Sonnino S. Adamo R, et al. Glycoconj J. 2020 Aug;37(4):511-512. doi: 10.1007/s10719-020-09929-9. Glycoconj J. 2020. PMID: 32504168 Free PMC article. No abstract available.
COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance.
Robson B. Robson B. Comput Biol Med. 2020 Jun;121:103749. doi: 10.1016/j.compbiomed.2020.103749. Epub 2020 Apr 11. Comput Biol Med. 2020. PMID: 32568687 Free PMC article. Review.

See all similar articles

Cited by

Surveillance of Post-Vaccination Side Effects of COVID-19 Vaccines among Saudi Population: A Real-World Estimation of Safety Profile.
Alzarea AI, Khan YH, Alatawi AD, Alanazi AS, Alzarea SI, Butt MH, Almalki ZS, Alahmari AK, Mallhi TH. Alzarea AI, et al. Vaccines (Basel). 2022 Jun 10;10(6):924. doi: 10.3390/vaccines10060924. Vaccines (Basel). 2022. PMID: 35746532 Free PMC article.
Lipid Nanoparticle-Based Delivery System-A Competing Place for mRNA Vaccines.
Zhang X, Li Y, Zhou Z. Zhang X, et al. ACS Omega. 2024 Jan 30;9(6):6219-6234. doi: 10.1021/acsomega.3c08353. eCollection 2024 Feb 13. ACS Omega. 2024. PMID: 38371811 Free PMC article. Review.
Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19.
Zhou H, Ni WJ, Huang W, Wang Z, Cai M, Sun YC. Zhou H, et al. Front Immunol. 2022 Apr 5;13:834942. doi: 10.3389/fimmu.2022.834942. eCollection 2022. Front Immunol. 2022. PMID: 35450063 Free PMC article. Review.
Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice.
Borgoyakova MB, Karpenko LI, Rudometov AP, Volosnikova EA, Merkuleva IA, Starostina EV, Zadorozhny AM, Isaeva AA, Nesmeyanova VS, Shanshin DV, Baranov KO, Volkova NV, Zaitsev BN, Orlova LA, Zaykovskaya AV, Pyankov OV, Danilenko ED, Bazhan SI, Shcherbakov DN, Taranin AV, Ilyichev AA. Borgoyakova MB, et al. Int J Mol Sci. 2022 Feb 16;23(4):2188. doi: 10.3390/ijms23042188. Int J Mol Sci. 2022. PMID: 35216301 Free PMC article.
COVID-19 vaccines and nanomedicine.
Shapiro RS. Shapiro RS. Int J Dermatol. 2021 Sep;60(9):1047-1052. doi: 10.1111/ijd.15673. Epub 2021 Jun 5. Int J Dermatol. 2021. PMID: 34089534 Free PMC article. Review.

See all "Cited by" articles

References

1. Moore JP, Klasse PJ. J. Virol. 2020;94:e01083–e20. doi: 10.1128/JVI.01083-20. - DOI - PMC - PubMed
1. Pallesen J, et al. Proc. Natl Acad. Sci. USA. 2017;114:E7348–E7357. doi: 10.1073/pnas.1707304114. - DOI - PMC - PubMed
1. Mercado, N. B. et al. Nature10.1038/s41586-020-2607-z (2020).
1. Corbett, K. S. et al. N. Engl. J. Med. 10.1056/NEJMoa2024671 (2020).
1. Keech, C. et al. N. Engl. J. Med. 10.1056/NEJMoa2026920 (2020).

Publication types

Actions

MeSH terms

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Miscellaneous
- NCI CPTAC Assay Portal